会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明公开
    • Cyclohexane derivatives
    • Cyclohexanderivate。
    • EP0142322A2
    • 1985-05-22
    • EP84307656.3
    • 1984-11-06
    • IMPERIAL CHEMICAL INDUSTRIES PLC
    • Guildford, Allen JohnTurner, Ralph William
    • C07C57/48C07C57/46C07C59/86C07C59/72C07C59/54C07C59/90C07C33/34C07C47/235C07C147/08C07C69/738
    • C07D319/08C07C33/34C07C45/305C07C45/40C07C45/41C07C47/235C07C57/46C07C57/48C07C59/54C07C59/72C07C59/86C07C59/90C07C317/00C07C321/00C07C403/20C07C2601/14C07C47/277
    • This invention concerns novel (4-substituted-2-phenylcyclohexyl)alkenoic and alkanoic acid derivatives of the formula I wherein one of Ra and Rb is hydrogen, hydroxy, (1-6C)alkyl, (1-6C)alkoxy, (3-6C)alkenyloxy or phenyl(1-4C)alkoxy and the other of Ra and Rb is hydrogen, (1-6C)alkyl, (1-6C)alkoxy or (3-6C)alkenyloxy: or Ra and Rb together form a (2-4)alkylenedioxy or oxo group; benzene ring X optionally bears a substituent selected from halogeno, (1-6C)alkyl, (1-6C)alkoxy, hydroxy, 12-6C) alkanoyloxy, (1-6C)alkanoylamino, trifluoromethyl and nitro; n is 3-5; Y is ethylene or vinylene; and in the cyclohexane ring, the substituents at positions 1 and 2 have cis- or trans -relative stereochemistry; and the pharmaceutically acceptable salts, (1-6C)alkyl esters and (1-6C)alkanesulphonamides thereof. The compounds of formula I possess valuable pharmacological properties of use in medicines. The invention also concerns processes for the manufacture of, and pharmaceutical compositions containing a novel compound of formula I.
    • 本发明涉及式I的新型(4-取代-2-苯基环己基)链烯酸衍生物,其中Ra和Rb之一是氢,羟基,(1-6C)烷基,(1-6C)烷氧基,(3- 6C)链烯氧基或苯基(1-4C)烷氧基,另一个R a和R b是氢,(1-6C)烷基,(1-6C)烷氧基或(3-6C)烯氧基; 或R a和R b一起形成(2-4C)亚烷基二氧基或氧代基团; 苯环X任选具有选自卤代,(1-6C)烷基,(1-6C)烷氧基,羟基,(2-6C)烷酰氧基,(1-6C)烷酰氨基,三氟甲基和硝基的取代基; n为3-5; Y是乙烯或亚乙烯基; 在环己烷环中,位置1和2的取代基具有顺式或反式相对立体化学; 和其药学上可接受的盐,(1-6C)烷基酯和(1-6C)烷基磺酰胺。 式I化合物具有药用中有价值的药理学性质。 本发明还涉及制备含有新型式I化合物的药物组合物和方法。